the level of protection from fatal fungal infection afforded by itraconazole was highly significant among patients who were granulocytopenic for more than 25 days ( p less than .0001 ) and among patients with acute lymphoblastic leukemia ( p = .008 ) .
C0026946
fungal infection
C0064113
itraconazole